A randomized, phase 2 study of R-CHOP plus enzastaurin vs R-CHOP in patients with intermediate- or high-risk diffuse large B-cell lymphoma

John D. Hainsworth, Edward R. Arrowsmith, Michael McCleod, Eric D. Hsi, Oday Hamid, Peipei Shi, Boris K. Lin, Luis E. Fayad

Research output: Contribution to journal › Letter › peer-review

22 Scopus citations

Fingerprint

Dive into the research topics of 'A randomized, phase 2 study of R-CHOP plus enzastaurin vs R-CHOP in patients with intermediate- or high-risk diffuse large B-cell lymphoma'. Together they form a unique fingerprint.